DAVID MARTINEZ – Trademark Portfolio
Entity Type: 01
DAVID MARTINEZ owns a portfolio of 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as GO 1-0 TODAY, ADDICTIVE INK, and STAY IN THE FIGHT. Of these, 5 are registered and 1 is pending. The portfolio spans 8 Nice Classification classes, led by Class 25 (Clothing) and Class 37 (Building & Construction). Headquartered in MONROVIA, CA.
417 Oakcliff Rd
MONROVIA, CA 91016
Showing of trademarks Trademarks
Trademark Classifications
DAVID MARTINEZ's trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does DAVID MARTINEZ have?
DAVID MARTINEZ has 9 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 3 abandoned.
What trademark classes does DAVID MARTINEZ file in?
DAVID MARTINEZ files trademarks across 8 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 37 (Building & Construction), Class 9 (Computers & Electronics), Class 43 (Hotels & Restaurants), Class 21 (Housewares). Class 25 covers clothing, footwear, headgear.
What are DAVID MARTINEZ's most well-known trademarks?
DAVID MARTINEZ's registered trademark portfolio includes well-known marks such as GO 1-0 TODAY, ADDICTIVE INK, and STAY IN THE FIGHT. These are among 5 currently registered trademarks in the portfolio.
What is DAVID MARTINEZ's trademark registration success rate?
DAVID MARTINEZ has a 63% trademark registration rate, with 5 out of 8 resolved applications resulting in successful registration. Currently, 1 application is pending review.